Could a Half-Dose malaria vaccine be just as good?
NCT ID NCT07194668
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tests whether a half-dose of the R21/Matrix-M malaria vaccine works as well as the full dose in 375 adults and adolescents aged 14 to 60. Participants will receive either the standard dose or one of two half-dose versions. The goal is to see if using less vaccine can still protect against malaria, which could help more people get vaccinated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alikadam Upazila Health Complex
Bāndarban, 4650, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lama Upazila Health Complex
Lāma, Lama, 4641, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.